CStone Pharmaceuticals — AGM Information 2022

Jun 7, 2022

==> picture [116 x 37] intentionally omitted <==

CStone Pharmaceuticals 基石藥業

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2616)

FORM OF PROXY FOR ANNUAL GENERAL MEETING

I/We (Name) of (Address) being the holder(s) of appoint (Name)

(Block capitals, please)

(see Note 1) shares of US$0.0001 each in the capital of CStone Pharmaceuticals (the “ Company ”) hereby

of (Address)

or failing him/her (Name)

of (Address)

or failing him/her, the chairman of the meeting (see Note 2) as my/our proxy to attend and vote for me/us and on my/our behalf at the Annual General Meeting of the Company to be held at 21/F, New Bund Times Square, No. 399 West Haiyang Road, Pudong New District, Shanghai, China on Thursday, June 30, 2022 at 9:00 a.m., and at any adjournment thereof or on any resolution or motion which is proposed thereat. My/our proxy is authorised and instructed to vote as indicated (see Note 3) in respect of the undermentioned resolutions:

		Ordinary Resolutions (see Note 3)	Ordinary Resolutions (see Note 3)			For	Against	Against
1.	To receive and consider the audited consolidated financial statements of the Company and the reports
	of the directors (“Directors”) and auditor of the Company for the year ended December 31, 2021
2.	(i)To re-elect Dr. Frank		Ningjun Jiang as an executive Director
	(ii)To re-elect Mr.	Yanling Cao as a non-executive Director
	(iii)To re-elect Mr.	Kenneth Walton Hitchner III as a non-executive Director
	(iv)To re-elect Mr.	Edward Hu as a non-executive Director
	(v)To re-elect Mr.	Ting Yuk Anthony Wu as an independent non-executive Director
3.	To authorise the board of Directors to fix the remuneration of the Directors
4.	To re-appoint Deloitte	Touche Tohmatsu as the auditor of the Company and authorise the board of
	Directors to fix their remuneration
5.	To grant a general mandate to		the Directors to allot, issue and deal with	additional shares not exceeding
	20% of the issued share capital of the Company
6.	To grant a general mandate to the Directors to buy back shares not exceeding 10% of the issued share
	capital of the Company
7.	To extend the authority	given to the Directors pursuant to ordinary resolution no. 5 to issue shares by
	adding to the issued share capital of the Company the number of shares bought back under ordinary
	resolution no. 6
Dated	thisday of		2022	Signature(s)			(see Note 5)

Notes:

1. Please insert the number of shares registered in your name(s); if no number is inserted, this form of proxy will be deemed to relate to all the shares in the capital of the Company registered in your name(s).

2. A member may appoint more than one proxy of his/her own choice. If such an appointment is made, strike out the words “the chairman of the meeting”, and insert the name(s) of the person(s) appointed as proxy in space provided. Any alteration made to this form of proxy must be initialled by the person who signs it.

3. IMPORTANT: IF YOU WISH TO VOTE FOR ANY RESOLUTION, PLEASE TICK THE BOX MARKED “For”. IF YOU WISH TO VOTE AGAINST ANY RESOLUTION, PLEASE TICK THE BOX MARKED “Against”. Failure to tick a box will entitle your proxy to cast your vote at his/her discretion. Your proxy will also be entitled to vote at his/her discretion on any resolution properly put to the meeting other than those referred to in the notice convening the meeting.

4. If the appointor is a corporation, this form must be under common seal or under the hand of an officer, attorney, or other person duly authorised on that behalf.

5. In the case of joint holders, the signature of any one holder will be sufficient but the names of all the joint holders should be stated. Where there are joint holders of any share of the Company, any one of such joint holders may vote at the meeting, either in person or by proxy, in respect of such share as if he/she were solely entitled thereto, but if more than one of such joint holders be present at the meeting, the vote of the senior who tenders a vote, whether in person or by proxy, will be accepted to the exclusion of the votes of the other joint holders, and for this purpose seniority shall be determined as that one of the said persons so present whose name stands first on the register in respect of such share shall alone be entitled to vote in respect thereof.

6. To be valid, this form of proxy must be completed, signed and deposited at the Company’s Share Registrar in Hong Kong, Computershare Hong Kong Investor Services Limited, at 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong together with the power of attorney or other authority (if any) under which it is signed (or a notarially certified copy thereof), not less than 48 hours before the time for holding the meeting (i.e. by no later than 9:00 a.m. on Tuesday, June 28, 2022). The completion and return of the form of proxy shall not preclude shareholders of the Company from attending and voting in person at the above meeting (or any adjourned meeting thereof) if they so wish.

7. A proxy need not be a shareholder of the Company.

PERSONAL INFORMATION COLLECTION STATEMENT

Your supply of your and your proxy’s (or proxies’) name(s) and address(es) is on a voluntary basis for the purpose of processing your request for the appointment of a proxy (or proxies) and your voting instructions for the above meeting of the Company (the ‘Purposes’). We may transfer your and your proxy’s (or proxies’) name(s) and address(es) to our agent, contractor, or third party service provider who provides administrative, computer and other services to us for use in connection with the Purposes and to such parties who are authorised by law to request the information or are otherwise relevant for the Purposes and need to receive the information. Your and your proxy’s (or proxies’) name(s) and address(es) will be retained for such period as may be necessary to fulfil the Purposes. Request for access to and/or correction of the relevant personal data can be made in accordance with the provisions of the Personal Data (Privacy) Ordinance and any such request should be in writing by mail to Computershare Hong Kong Investor Services Limited at the above address.